Ledger.Open graph →
SEC Form D · filed January 10, 2023

ImmuneBridge Inc

Offering
$14.2M
Sold
$10.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Alicia A. Jackson · San Francisco, CADirectorDylan K. Morris · San Francisco, CADirectorRobert J. Hugin · New York, NYDirectorCheryl K. Zimberlin · San Francisco, CADirectorGregory A. Bonfiglio · South San Francisco, CADirectorPeretz Partensky · San Francisco, CAExec · DirectorMary K. Warren · San Francisco, CADirectorMark P. Sealy · Irving, TXDirectorCheryl K. Zimberlin · San Francisco, CADirectorGregory A. Bonfiglio · San Francisco, CADirectorPeretz Partensky · San Francisco, CAExec · DirectorDylan K. Morris · San Francisco, CADirectorMary K. Warren · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗